Omega Therapeutics Inc
NASDAQ:OMGA
Omega Therapeutics Inc
Cash Interest Paid
Omega Therapeutics Inc
Cash Interest Paid Peer Comparison
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Omega Therapeutics Inc
NASDAQ:OMGA
|
Cash Interest Paid
$1.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Interest Paid
$42m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
5%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Omega Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
1.7m
USD
Based on the financial report for Dec 31, 2023, Omega Therapeutics Inc's Cash Interest Paid amounts to 1.7m USD.
What is Omega Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
33%
Over the last year, the Cash Interest Paid growth was 37%. The average annual Cash Interest Paid growth rates for Omega Therapeutics Inc have been 33% over the past three years .